Abstract：
Artificial intelligence (AI) is revolutionizing dermatology by enhancing diagnostic accuracy and offering personalized treatment recommendations based on individual patient characteristics and medical history. This month\'s editorial discusses the transformative role of AI in dermatology, emphasizing its potential to enhance diagnostic accuracy, personalize treatment, and improve healthcare delivery efficiency. It highlights three manuscripts addressing AI\'s applications in dermatopathology, climate change-related skin disorders, and health care for undocumented immigrants. Ethical concerns, such as AI transparency and overdiagnosis, are also noted. Additionally, new treatments for atopic dermatitis (AD) are examined. We specifically recommend two recent reports on the efficacy of dupilumab in pediatric AD and refractory hand eczema (HE), demonstrating advancements in dermatological therapy for treatment-resistant conditions.
摘要：
人工智能（AI）通过提高诊断准确性并根据个体患者特征和病史提供个性化治疗建议，正在彻底改变皮肤病学。本月的社论讨论了人工智能在皮肤病学中的变革作用，强调其提高诊断准确性的潜力，个性化治疗，提高医疗服务效率。它重点介绍了三篇关于人工智能在皮肤病理学中的应用的手稿，与气候变化有关的皮肤病，和无证移民的医疗保健。伦理问题,比如人工智能透明度和过度诊断，也注意到。此外,研究了特应性皮炎（AD）的新疗法。我们特别推荐两篇关于dupilumab在小儿AD和难治性手部湿疹（HE）中的疗效的最新报告，证明了皮肤病治疗抵抗疾病的进展。
